Image Place holder

Jad Chahoud, MD, MPH

Academic Rank: Assistant Member

Overview


Discipline

    • Genitourinary Oncology
    • Immuno-Oncology

Education & Training

Board Certification:

  • Internal Medicine

Fellowship:

  • University of Texas Health Sciences Center, MPH - Public Health
  • Lebanese University Faculty of Medical Sciences, MD - Medicine
  • University of Texas Health Science Center, -
  • University of Texas MD Anderson Cancer Center, -
Publications

  • Chahoud J, McGettigan M, Parikh N, Boris RS, Iliopoulos O, Rathmell WK, Daniels AB, Jonasch E, Spiess PE. Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol. 2020 Sep. Pubmedid: 32936333.
  • Chahoud J, Tamil M, Necchi A. Second line salvage systemic therapy for advanced penile cancer. Urol Oncol. 2020 Sep. Pubmedid: 32950396.
  • Berglund A, Amankwah EK, Kim YC, Spiess PE, Sexton WJ, Manley B, Park HY, Wang L, Chahoud J, Chakrabarti R, Yeo CD, Luu HN, Pietro GD, Parker A, Park JY. Influence of gene expression on survival of clear cell renal cell carcinoma. Cancer Med. 2020 Sep.9(22):8662-8675. Pubmedid: 32986937. Pmcid: PMC7666730.
  • Hajiran A, Zemp L, Aydin AM, Cheryian SK, Pow-Sang JM, Chahoud J, Spiess PE. Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. Urol Oncol. 2020 Oct.39(1):72.e1-72.e5. Pubmedid: 33036902.
  • Ahmed ME, Falasiri S, Hajiran A, Chahoud J, Spiess PE. The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy. J Clin Med. 2020 Oct.9(10). Pubmedid: 33080912. Pmcid: PMC7603091.
  • Safa H, Tamil M, Spiess PE, Manley B, Pow-Sang J, Gilbert S, Safa F, Gonzalez BD, Oswald LB, Semaan A, Diab A, Chahoud J. Patient Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals from 2011 to 2018: A Systematic Review. J Natl Cancer Inst. 2020 Nov. Pubmedid: 33146385.
  • Chahoud J, Msaouel P, Ross JA, McCormick BZ, Bathala TK, Gao J, Horn R, Xiao L, Sircar K, Campbell MT, Shah AY, Goswami S, Zurita AJ, Jonasch E, Matin SF, Wood CG, Karam JA, Sharma P, Tannir NM. Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. Urol Oncol. 2020 Nov. Pubmedid: 33187886.
  • Huang T, Cheng X, Chahoud J, Sarhan A, Tamboli P, Rao P, Guo M, Manyam G, Zhang L, Xiang Y, Han L, Shang X, Deng P, Luo Y, Lu X, Feng S, Ferrer MM, Alan Wang Y, DePinho RA, Pettaway CA, Lu X. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun. 2020 May.11(1):2124. Pubmedid: 32358507. Pmcid: PMC7195486.
  • Chahoud J, Msaouel P, Campbell MT, Bathala T, Xiao L, Gao J, Zurita AJ, Shah AY, Jonasch E, Sharma P, Tannir NM. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis. Oncologist. 2020 Mar.25(3):252-258. Pubmedid: 32162795. Pmcid: PMC7066696.
  • Azizi M, Aydin AM, Hajiran A, Lai A, Kumar A, Peyton CC, Minhas S, Sonpavde GP, Chahoud J, Pagliaro LC, Necchi A, Spiess PE. Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?. J Urol. 2020 Jun.203(6):1147-1155. Pubmedid: 31928407.
  • Azizi M, Aydin AM, Hajiran A, Lai A, Kumar A, Peyton CC, Minhas S, Sonpavde GP, Chahoud J, Pagliaro LC, Necchi A, Spiess PE. Reply by Authors. J Urol. 2020 Jun.203(6):1155. Pubmedid: 32176595.
  • Terrisse S, Karamouza E, Parker CC, Sartor AO, James ND, Pirrie S, Collette L, Tombal BF, Chahoud J, Smeland S, Erikstein B, Pignon JP, Fizazi K, Le Teuff G. Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical Trials. JAMA Oncol. 2020 Feb.6(2):206-216. Pubmedid: 31830233. Pmcid: PMC6990736.
  • Chahoud J, Kohli M, Spiess PE. Management of Advanced Penile Cancer. Mayo Clin Proc. 2020 Dec. Pubmedid: 33308870.
  • Hajiran A, Chakiryan N, Aydin AM, Zemp L, Nguyen J, Laborde JM, Chahoud J, Spiess PE, Zaman S, Falasiri S, Fournier M, Teer JK, Dhillon J, McCarthy S, Moran-Segura C, Katende EN, Sexton WJ, Koomen JM, Mulé J, Kim Y, Manley B. Reconnaissance of Tumor Immune Microenvironment Spatial Heterogeneity in Metastatic Renal Cell Carcinoma and Correlation with Immunotherapy Response. Clin Exp Immunol. 2020 Dec. Pubmedid: 33346915.
  • Aydin AM, Chahoud J, Adashek JJ, Azizi M, Magliocco A, Ross JS, Necchi A, Spiess PE. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat Rev Urol. 2020 Aug.17(10):555-570. Pubmedid: 32812000.
  • Chahoud J, Msaouel P, Campbell MT, Bathala T, Xiao L, Gao J, Zurita AJ, Shah AY, Jonasch E, Sharma P, Tannir NM. Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis. Oncologist. 2019 Sep. Pubmedid: 31501271.
  • Chahoud J, Pickering CR, Pettaway CA. Genetics and penile cancer: recent developments and implications. Curr Opin Urol. 2019 Jul.29(4):364-370. Pubmedid: 31045928.
  • Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 Oct.16(5):325-327. Pubmedid: 29807831.
  • Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol. 2018 May.30(3):181-188. Pubmedid: 29538040.
  • Chahoud J, Sui D, Erwin WD, Gulbis AM, Korbling M, Zhang M, Ahmed S, Alatrash G, Anderlini P, Ciurea SO, Oran B, Fayad LE, Bassett RL, Jabbour EJ, Medeiros LJ, Macapinlac HA, Young KH, Khouri IF. Updated Results of Rituximab Pre- and Post-BEAM with or without Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2018 May.24(10):2304-2311. Pubmedid: 29476021. Pmcid: PMC5955837.
  • Chahoud J, Rieber AG, Tyring SK. The β-HPV Subtypes-Cornerstone of the Next-Generation Vaccine. JAMA Oncol. 2017 May.3(5):594-595. Pubmedid: 27893031.
  • Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-Sided Infective Endocarditis and Pulmonary Infiltrates: An Update. Cardiol Rev. 2016 Sep.24(5):230-237. Pubmedid: 26501991.
  • Chahoud J, Semaan A, Chen Y, Cao M, Rieber AG, Rady P, Tyring SK. Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis. JAMA Dermatol. 2016 Dec.152(12):1354-1364. Pubmedid: 26720285.
  • Chahoud J, Semaan A, Rieber A. Wealth, Health Expenditure, and Cancer: A National Perspective. J Natl Compr Canc Ne. 2016 Aug.14(8):972-978. Pubmedid: 27496113.
  • Chahoud J, Semaan A, Rieber A. Counterpoint: Wealth, Health Expenditure, and Cancer-Translating Research Into Efficient Policies. J Natl Compr Canc Ne. 2016 Aug.14(8):1043. Pubmedid: 27496120.
  • Chahoud J, Semaan A, Almoosa KF. Ventilator-associated events prevention, learning lessons from the past: A systematic review. Heart Lung. 2015 May.44(3):251-259. Pubmedid: 25686517.
  • Chahoud J, Mrad J, Semaan A, Asmar R. PREVALENCE OF DIABETES MELLITUS AMONG PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION. J Med Liban. 2015 Apr.63(2):74-80. Pubmedid: 26164975.
  • Chahoud J, Kanafani Z, Kanj SS. Surgical site infections following spine surgery: eliminating the controversies in the diagnosis. Front Med (Lausanne). 2014 Mar.1:7. Pubmedid: 25705620. Pmcid: PMC4335387.
  • Chahoud J, Kanafani ZA, Kanj SS. Management of candidaemia and invasive candidiasis in critically ill patients. Int J Antimicrob Agents. 2013 Jun.42 Suppl:S29-S35. Pubmedid: 23664579.